LVW Advisors, LLC

SEC CIK: 0001576053
Latest filing: Jul 15, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by LVW Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q2 2026): 12,000
Value: $44.0K
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2025

Holdings of RXRX by LVW Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	12,000	$44.0K	<0.1%	+12,000	New	Holders
Q1 2026	0	$0	0.0%	−13,000−100.0%	Sold out	Holders
Q4 2025	13,000	$53.2K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	13,000	$63.4K	<0.1%	+13,000	New	Holders